Original Article/Pancreas
Increasing pancreatic cancer is not paralleled by pancreaticoduodenectomy volumes in Brazil: A time trend analysis

https://doi.org/10.1016/j.hbpd.2018.12.007Get rights and content

Abstract

Background

Currently, surgical resection represents the only curative treatment for pancreatic cancer (PC), however, the majority of tumors are no longer resectable by the time of diagnosis. The aim of this study was to describe time trends and distribution of pancreaticoduodenectomies (PDs) performed for treating PC in Brazil in recent years.

Methods

Data were retrospectively obtained from Brazilian Health Public System (namely DATASUS) regarding hospitalizations for PC and PD in Brazil from January 2008 to December 2015. PC and PD rates and their mortalities were estimated from DATASUS hospitalizations and analyzed for age, gender and demographic characteristics.

Results

A total of 2364 PDs were retrieved. Albeit PC incidence more than doubled, the number of PDs increased only 37%. Most PDs were performed in men (52.2%) and patients between 50 and 69 years old (59.5%). Patients not surgically treated and those 70 years or older had the highest in-hospital mortality rates. The most developed regions (Southeast and South) as well as large metropolitan integrated municipalities registered 76.2% and 54.8% of the procedures, respectively. LMIM PD mortality fluctuated, ranging from 13.6% in 2008 to 11.8% in 2015.

Conclusions

This study suggests a trend towards regionalization and volume-outcome relationships for PD due to PC, as large metropolitan integrated municipalities registered most of the PDs and more stable mortality rates. The substantial differences between PD and PC increasing rates reveals a limiting step on the health system resoluteness. Reduction in the number of hospital beds and late access to hospitalization, despite improvement in diagnostic methods, could at least in part explain these findings.

Introduction

Pancreatic cancer (PC) is the 4th leading cause of death worldwide [1]. In Brazil, PC is the 13th most prevalent cancer in men and the 10th most prevalent in women [2]. PC incidence and mortality rates are increasing in most parts of the world, being higher in high-income areas, intermediate in South and Central America and Eastern Asia, and lower in low-income areas [3], [4]–5]. Although there has been an overall reduction in tobacco-related neoplasms in Europe and North America, PC mortality trends for the next years and decades is not favorable [6], [7], [8]–9].

The only potentially curative therapy for PC is complete surgical resection but, at the time of diagnosis, 80%–90% of the tumors are no longer resectable [10], [11]. Most PCs involve the pancreatic head, location that determines whether the patient will undergo a pancreaticoduodenectomy (PD), the Whipple procedure. PD is an abdominal operation with a significant risk of postoperative morbidity and mortality [12], [13]. Risk factors for pancreatic surgery are related to the pancreatic characteristics, age of the patients, comorbidities, and also to the procedure itself [13]. On the other hand, due to consistent progress in surgical procedures, operative rates for pancreatic tumors have increased significantly, being offered even to older patients with additional comorbidities [14], [15]. Recent data suggest that a certain critical caseload volume is required to undertake this kind of surgery with low mortality, because the results probably are influenced by case volume per surgeon and institution [16], [17]. Major centers in Western countries report remarkably low rates of perioperative mortality, of less than 5% [18], [19]. Nevertheless, there are considerable variations among centers worldwide. Hence, the value of regionalization and centralization of PD procedures has been under debate [20], [21].

In Brazil, a recent study observed that PC incidence rates increased 87% from 2005 to 2012. Such increase in PC rates was mainly driven by people over 50 years old [22]. However, population-based data on cancer treatment are still limited in the country. Therefore, the aim of this study was to analyze rates, age-related in-hospital mortality and time trends of PD for PC in Brazil. In particular, demographic and geographic aspects related to urbanization and conurbation were taken into account, in order to evaluate possible patterns of regionalization and their potential influence in outcomes.

Section snippets

Data source

Data from the Health Informatics Department of the Brazilian Ministry of Health (DATASUS) (http://www2.datasus.gov.br/DATASUS) were searched. DATASUS registries include hospital admission and discharge information, medical procedures and mortality, reference tables and demographic data (age, gender, municipality) collected by the Instituto Brasileiro de Geografia e Estatística (IBGE; Brazilian Institute of Geography and Statistics). Patients under 20 years old were excluded. PC incidence and PD

Hospitalizations for pancreatic cancer

The age-standardized incidence for PC in Brazil, estimated from hospitalizations, increased 121.4% in men (from 2.8 to 6.2 per 100 000 inhabitants) and 136% in women (from 2.5 to 5.9 per 100 000 inhabitants) in the study period. Incidence by gender were higher in men (52.2%) than in women (47.8%) and the male/female incidence ratio was 1.05:1 (Fig. 1A).

Pancreatoduodenectomy numbers, mortality, and their trends

From 2008–2015, an estimated 2364 PDs were performed for PC in Brazil in people 20 years or older. The number of procedures performed annually

Discussion

In this study, we describe for the first time to our knowledge, data on the PD surgical treatment for PC in Brazil over a recent period of time (2008 to 2015).

PD, with the possible addition of neoadjuvant or adjuvant therapy, is the current standard of care for adenocarcinoma originating in the pancreatic head, neck and uncinate process [24], [25]. Although PD was developed in the early thirties, it became more frequent only after the 1980s, when highly complex surgical digestive centers

Contributors

PSLM participated in the conception and design of the study, the acquisition, analysis, and interpretation of the data, and the drafting of the manuscript. MJPL, FHS, and EJMR participated in the acquisition, analysis, and interpretation of the data and the drafting of parts of the manuscript. LRR and SHSP participated in the conception and design of the study, analyzed and interpreted the data, and critically revised the manuscript for important intellectual content. All authors gave final

Funding

This study was supported by grants from Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro - FAPERJ [E-26/2014-202.008] and Conselho Nacional de Desenvolvimento Científico e Tecnológico – CNPq [302401/2016-4].

Ethical approval

Not needed.

Competing interest

No benefits in any form have been received or will be received from a commercial party related directly or indirectly to the subject of this article.

References (46)

  • LG van der Geest et al.

    Volume-outcome relationships in pancreatoduodenectomy for cancer

    HPB (Oxford)

    (2016)
  • G Balzano et al.

    Overuse of surgery in patients with pancreatic cancer. A nationwide analysis in Italy

    HPB (Oxford)

    (2016)
  • MC Machado et al.

    Systematic use of isolated pancreatic anastomosis after pancreatoduodenectomy: five years of experience with zero mortality

    Eur J Surg Oncol

    (2016)
  • Cancer incidence, mortality and prevalence worldwide

    Globocan

    (2012)
  • Pancreas cancer Brazil

    (2008)
  • P Maisonneuve et al.

    Epidemiology of pancreatic cancer: an update

    Dig Dis

    (2010)
  • M Del Chiaro et al.

    Early detection and prevention of pancreatic cancer: is it really possible today?

    World J Gastroenterol

    (2014)
  • L Rahib et al.

    Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States

    Cancer Res

    (2014)
  • ChenWQ et al.

    Report of cancer incidence and mortality in China, 2014

    Zhonghua Zhong Liu Za Zhi

    (2018)
  • P Kongkam et al.

    Pancreatic cancer in an Asian population

    Endosc Ultrasound

    (2015)
  • C Fristrup et al.

    Danish pancreatic cancer database

    Clin Epidemiol

    (2016)
  • J Ng et al.

    Locally advanced pancreatic adenocarcinoma: update and progress

    JOP

    (2012)
  • M Zovak et al.

    Pancreatic surgery: evolution and current tailored approach

    Hepatobiliary Surg Nutr

    (2014)
  • View full text